Insurance Rachel Cohrs STAT Plus: Medicare couldn’t cover Wegovy for weight loss. But now that it’s also a heart drug, the door is open
Health tech Casey Ross STAT Plus: Q&A: Amid AI frenzy in medicine, a federal regulator’s quest to create safeguards
Adam's Take Adam Feuerstein STAT Plus: Argenx readies another blockbuster opportunity with its antibody drug
Politics John Wilkerson STAT Plus: BIO severs ties with WuXi in the face of U.S. government concerns over China
Health Tara Bannow STAT Plus: RaDonda Vaught, former Vanderbilt nurse who accidentally killed patient, says hospital issues contributed, too
Biotech Matthew Herper and Jason Mast STAT Plus: Small studies offer hope CAR-T can fight an aggressive brain cancer
Health Angus Chen STAT Plus: In large trial, Guardant Health’s blood test detects colon cancer, but less reliably at earliest or precancerous stages
Pharmalot Ed Silverman STAT Plus: Pharma loses a key battle over a state law concerning 340B pharmacies
First Opinion Benjamin Chartock STAT Plus: Good health care price transparency rules are at risk if Congress doesn’t act
Health tech Mohana Ravindranath STAT Plus: AI health care companies say they’ll keep humans in the loop. But what does that actually mean?
Biotech Jason Mast STAT Plus: Hemophilia gene therapies arrived after 40 years of struggle. Where are the patients?
Hospitals Katie Palmer and Casey Ross STAT Plus: Hospitals struggle to validate AI-generated clinical summaries. ‘It’s a bit chaotic’
Health Annalisa Merelli After Amylyx ALS trial failure, patients share disappointment and fear — but some hope
Politics John Wilkerson and Sarah Owermohle STAT Plus: Here’s what you might have missed in Biden’s budget proposal
Hospitals Jon Chesto — Boston Globe STAT Plus: For-profit health system’s Mass. hospitals teetering on the brink of financial disaster
Health tech Lizzy Lawrence STAT Plus: Researchers create talking throat patch for people with voice disorders
First Opinion Paul Law No parent who has seen the children I’ve treated for measles would refuse a vaccine
The War on Recovery Lev Facher Rigid rules at methadone clinics are jeopardizing patients’ path to recovery from opioid addiction
Biotech Adam Feuerstein STAT Plus: First medicine developed to treat MASH expected to be approved soon
The War on Recovery Lev Facher STAT Plus: New methadone rules are about to take effect. Here are 6 ways treatment could shift
Biotech Adam Feuerstein STAT Plus: Acadia’s Nuplazid fails as treatment for schizophrenia in Phase 3 study
Health Theresa Gaffney Experts say leaked messages present false link between gender-affirming care and cancer
Health tech Andrew Joseph STAT Plus: U.K. researchers warn about biases in medical devices, health care algorithms
Health Saima May Sidik Amid the battle over abortion rights, a failure to agree on how to define abortion